CRISPR Therapeutics AG financial statements, including revenue, expenses, profit, and loss

The total revenue of CRSP for the last quarter is 602.00 k USD, and it's 16.44% higher compared to the previous quarter. The net income of Q3 24 is -85.94 M USD.